• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

Altered substrate recognition of mutant enzymes which catalyzes hydrolysis of oligosuccharide chain, and related with clinical phenotype and straged substrates.

Research Project

Project/Area Number 06672311
Research Category

Grant-in-Aid for General Scientific Research (C)

Allocation TypeSingle-year Grants
Research Field Laboratory medicine
Research InstitutionThe Tokyo Metropolitan Institute of Medical Science

Principal Investigator

FUKUHARA Yukiko  The Tokyo Metropolitan Institute of Medical Science, Department of Tumor Cell Biology, Researcher, 腫瘍細胞研究部門, 研究員 (10124489)

Co-Investigator(Kenkyū-buntansha) SUZUKI Yosiyuki  The Tokyo Metropolitan Institute of Medical Science, Vice-Director, 副所長 (90010389)
Project Period (FY) 1994 – 1995
Project Status Completed (Fiscal Year 1995)
Budget Amount *help
¥1,400,000 (Direct Cost: ¥1,400,000)
Fiscal Year 1995: ¥600,000 (Direct Cost: ¥600,000)
Fiscal Year 1994: ¥800,000 (Direct Cost: ¥800,000)
Keywordsbeta-galactosidase / Morquio B disease / GM1 gangliosidosis / gene mutation / Km / substrates / Baculovirus expressed protein
Research Abstract

beta-galactosidase is the enzyme that catalyzes hydrolysis of the terminal beta1-4 or 1-3 galactoside linkage in the oligosuccharide chain of complex carbohydrates. Mutations of the gene coding for this enzyme result in hereditary disease in human with phenotypic variations, represented by GM1 gangliosidosis and Morquio B disease. Their manifestions are based on different mutations of the same gene, suggesting different catalytic proteins and tissue expressions of mutant enzymes. In this study, we expressed mutant cDNAs of point mutation in GM1 gangliosidosis : I51T (adult type) , R201C (juvenile type) and G123R (infantile) , and in Morquio B disease : W273L by the Baculovirus system for characterization of mutant enzymes. Ferthermore, we considered that it could clarified the relation between phenotypic variations and substrates storaged in patient body. We have failed to obtain amount of mutant protein all types of GM1 gangliosidosis, because of not secreting but remaining in Sf-9 ce … More lls. The result implied that causing abnormal processing of succharide chain in mutant protein from GM1 gangliosidosis. Only W273L mutant protein from Morquio B disease was obtained by Baculovirus system. Normal and W273L mutant protein were purified precursor (84kDa) and mature (64kDa) proteins by various column chromatographies, and assayd their catalytic activities toward MU-Gal substrate, GM1 ganglioside, oligosuccharide and keratan sulfate. 1) Normal 84kDa and 64kDa protein each has distinct character (Km, optimun pH,effect on detergent). 2) Km of W273L mutant 84kDa was same as normal, but Vmax of mutant was 1/20 of normal Vmax. 3) W273L mutant 64kDa almost lost its catalytic activity. 4) Affinity of mutant 84kDa protein toward p-aminophenyl beta-D-thiogalactopyranoside, analogue substrate, was lower than normal. 5) Mutant 84kDa has catalytic activity toward GM1 ganglioside, natural substrate, but not toward keratan sulfate which was stored in patient urea. These results suggested that the residual activity of mutant precursor protein toward beta-1,4 galactoside linkage saved Morquio B dissease patients from mental retardation which is severe in GM1 gangliosidosis. Less

Report

(3 results)
  • 1995 Annual Research Report   Final Research Report Summary
  • 1994 Annual Research Report
  • Research Products

    (15 results)

All Other

All Publications (15 results)

  • [Publications] Oshima, A., et al.: "Intracellular processing and maturation of mutant gene products in hereditaty β-galactosidase deficiency(β-galactosidasis)" Human Genetics. 93. 109-114 (1994)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      1995 Final Research Report Summary
  • [Publications] Ishii, N., et al.: "β-galactosidosis(Genetic β-Galactosidase Deficiency): Clinical and genetic Heterogeneity of the Skeletal Form" Developemental Brain Dysfunctions;. 8. 40-50 (1995)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      1995 Final Research Report Summary
  • [Publications] Akira Satake, et al.: "Distribution of Lysosomal Protective Protein in Human Tissues" Biochem. Biophys. Res. Commun.,. 205. 38-43 (1994)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      1995 Final Research Report Summary
  • [Publications] Ishii, N., et al.: "Normal Serum β-Galactosidase in Juvenile GM1 Gangliosidosis" PEDIATRIC NEUROLOGY,. 10. 317-319 (1994)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      1995 Final Research Report Summary
  • [Publications] Ishii, N., et al.: "Clinical and molecular analysis of a japanese boy with Morquio B disease" Clinical Genetics,. 48. 103-108 (1995)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      1995 Final Research Report Summary
  • [Publications] Akihiro Oshima, Kunihiro Yoshida, Kohji Itoh, Ryoichi Kase, Hitoshi Sakuraba, Yoshiyuki Suzuki: "Intracellular processing and maturation of mutant gene products in hereditary beta-galactosidase deficiency (beta-galactosidosis)" Hum.Genet. 93. 109-114 (1994)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      1995 Final Research Report Summary
  • [Publications] Nozomi Ishii, Akihiro Oshima, Hitoshi sakuraba, Makiko Ozawa, Yoshiyuki Suzuki: "beta-Galactosidosis (Genetic beta-Galactosidase Deficiency) : Clinical and Genetic Heterogeneity of the Skeletal Form" Developmental Brain Dysfunction. 8. 40-50 (1995)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      1995 Final Research Report Summary
  • [Publications] Nozomi Ishii, MD,Akihiro Oshima, MD,Hitoshi sakuraba, MD,Yukio Fukuyama, MD,and Yoshiyuki Suzuki, MD.: "Normal Serum beta-Galactosidase in Juvenile GM1-Gangliosidosis" Pediatric Neurology. 10. 317-319 (1994)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      1995 Final Research Report Summary
  • [Publications] Akira Satake, Kohji Itoh, Michie Shimmoto, Takaomi C.Saido, Hitoshi Sakuraba, and Yoshiyuki Suzuki: "Distribution of Lysozomal Protective Protein in Human Tissues." Biochemical and Biophysical Researc Communications. 205. 38-43 (1994)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      1995 Final Research Report Summary
  • [Publications] Ishii N,Oohira T,Oshima A,Sakuraba H,Endo F,Matuda I,Sukegawa K,Orii T,Suzuki Y.: "Clinical and molecular analysis of a Japanese boy with Morquio B disease." Clinical Genetics.48. 103-108 (1995)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      1995 Final Research Report Summary
  • [Publications] Oshima, A., et al: "Intracellular processing and maturation of mutant gene products in hereditary β-galactosidase deficienccy(β-galactosidosis)" Human Genetics. 93. 109-114 (1994)

    • Related Report
      1995 Annual Research Report
  • [Publications] Ishii, N., et al.: "β-galactosidosis(Genetic β-Galactosidase Deficiency):Clinical and genetic Heterogeneity of the Skeletal Form" Developmental Brain Dysfunction. 8,. 40-50 (1995)

    • Related Report
      1995 Annual Research Report
  • [Publications] Akira Satake, et al.: "Distribution of Lysosomal Protective Protein in Human Tissues" Biochem. Biophys. Res. Commun.205. 38-43 (1994)

    • Related Report
      1995 Annual Research Report
  • [Publications] Ishii, N., et al.: "Normal Serum β-Galactosidase in Juvenile GM1 Gangliosidosis" PEDIATRIC NEUROLOGY. 10,. 317-319 (1994)

    • Related Report
      1995 Annual Research Report
  • [Publications] Ishii, N., et al.: "Clinical and molecular analysis of a japanese boy with Morquio B disease" Clinical Genetics,. 48,. 103-108 (1995,)

    • Related Report
      1995 Annual Research Report

URL: 

Published: 1994-04-01   Modified: 2016-04-21  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi